Cargando…

Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma

In order to elucidate the clinical significance of the erbB family, epidermal growth factor receptor (EGF-R), c-erbB-2, c-erbB-3 and c-erbB-4 in hepatocellular carcinoma (HCC), we investigated the expression of these proteins by means of immunohistochemistry for HCC as well as adjacent noncancerous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Y, Takeda, T, Sakon, M, Tsujimoto, M, Higashiyama, S, Noda, K, Miyoshi, E, Monden, M, Matsuura, N
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363640/ https://www.ncbi.nlm.nih.gov/pubmed/11355950 http://dx.doi.org/10.1054/bjoc.2000.1580

Ejemplares similares

Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma
por: Ito, Y, et al.
Publicado: (1999)

The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma
por: Ito, Y, et al.
Publicado: (2000)

Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial
por: Kawata, S, et al.
Publicado: (2001)

Elevated expression of thyroid hormone receptor α 2 (c-erb A- α 2) in nasopharyngeal carcinoma
por: Lee, J-W, et al.
Publicado: (2000)

Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6
por: Kurebayashi, J, et al.
Publicado: (1999)

Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues.
por: Ito, Y., et al.
Publicado: (1996)

Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus
por: Nishioka, K, et al.
Publicado: (2001)

Clinical Significance of ErbB Receptor Family in Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-Analysis
por: Tsai, Yuh-Shyan, et al.
Publicado: (2012)

Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma
por: Saffroy, R, et al.
Publicado: (1999)

Activation of Wnt/β-catenin signalling pathway induces chemoresistance to interferon-α/5-fluorouracil combination therapy for hepatocellular carcinoma
por: Noda, T, et al.
Publicado: (2009)

The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells
por: Trerè, D, et al.
Publicado: (1999)

Upregulation of the ErbB family by EZH2 in hepatocellular carcinoma confers resistance to FGFR inhibitor
por: Prawira, Aldo, et al.
Publicado: (2021)

c-erbB-4 protein expression in human breast cancer
por: Kew, T Y, et al.
Publicado: (2000)

Expressions of Fas ligand and other apoptosis-related genes and their prognostic significance in epithelial ovarian neoplasms
por: Munakata*, S, et al.
Publicado: (2000)

Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma
por: Breitenecker, Kristina, et al.
Publicado: (2023)

Hepatocellular carcinoma
por: Giovannini, M, et al.
Publicado: (2001)

Peroxisome proliferator-activated receptor γ ligand-induced growth inhibition of human hepatocellular carcinoma
por: Rumi, M A K, et al.
Publicado: (2001)

Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors
por: Villa, E, et al.
Publicado: (2001)

Significance of epidermal growth factor receptor and c-erbB-2 protein expression in transitional cell cancer of the upper urinary tract for tumour recurrence at the urinary bladder.
por: Imai, T., et al.
Publicado: (1995)

Phosphotyrosine interactome of the ErbB-receptor kinase family
por: Schulze, Waltraud X, et al.
Publicado: (2005)

Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin
por: Yoo, J-Y, et al.
Publicado: (2000)

Clinicopathological significance of concurrent ErbB receptor expression in human meningioma
por: Torp, Sverre Helge, et al.
Publicado: (2023)

p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung
por: Huang, C-I, et al.
Publicado: (2000)

Negative regulation of ErbB family receptor tyrosine kinases
por: Sweeney, C, et al.
Publicado: (2004)

Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer
por: Houston, S J, et al.
Publicado: (1999)

Gene expression profiles in thyroid carcinomas
por: Takano, T, et al.
Publicado: (2000)

Identification and characterization of a novel human hepatocellular carcinoma-associated gene
por: Wang, Z-X, et al.
Publicado: (2001)

Clinicopathologic significance of sialyl Le (x)expression in advanced gastric carcinoma
por: Futamura, N, et al.
Publicado: (2000)

Estrogen receptor transcription and transactivation: ErbB family of receptors in breast cancer
por: Hynes, NE, et al.
Publicado: (2001)

Betel quid chewing as a risk factor for hepatocellular carcinoma: a case-control study
por: Tsai, J F, et al.
Publicado: (2001)

Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients
por: Kimura, M, et al.
Publicado: (1999)

ErbB2 Is Necessary for Induction of Carcinoma Cell Invasion by Erbb Family Receptor Tyrosine Kinases
por: Spencer, Kathryn S.R., et al.
Publicado: (2000)

Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma
por: Shen, G H, et al.
Publicado: (2000)

Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan
por: Sheu, J-C, et al.
Publicado: (1999)

c-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates
por: Mezzelani, A, et al.
Publicado: (1999)

The clinical significance of MMP-1 expression in oesophageal carcinoma
por: Yamashita, K, et al.
Publicado: (2001)

PTEN/MMAC1 Mutation and Frequent Loss of Heterozygosity Identified in Chromosome 10q in a Subset of Hepatocellular Carcinomas
por: Fujiwara, Yoshiyuki, et al.
Publicado: (2000)

Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression
por: Ota, H, et al.
Publicado: (2005)

Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization
por: Miyasaka, Y, et al.
Publicado: (2001)

Syndecan-1 expression has prognostic significance in head and neck carcinoma
por: Anttonen, A, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_p44fv30umvihsnnsmg79qf155m